Signs Away the Power: Read Before You Sign
| Law, Business & Power Correspondent | PUCKA by News Beast --- €0.
By Harvey Specter Jr. | Law, Business & Power Correspondent | PUCKA by News Beast
---
€0. That is what most people recover when they sign something without reading it, then discover three years later that the document they treated as a formality was actually a weapon pointed at them.
Prediction markets are having a moment. Kalshi just partnered with AppliedXL to launch markets tied to clinical trial outcomes and FDA regulatory decisions. ADI Predictstreet is pushing the same architecture into Latin America through FIRST.bet. The structure is elegant and the pitch is compelling — crowds of informed participants pricing probability better than any single analyst. But strip away the technology and what you have is a contract. And buried inside every one of those contracts is a clause that the person who signed it did not read, and the person who wrote it is counting on them never reading.
I have seen this exact mechanic in Malta. Not with prediction markets — with employment agreements, with commercial leases, with service contracts handed across a desk with a pen already uncapped. The unwritten rule of every lopsided contract is simple: the drafter wins if you don't read it, and the drafter wins twice if you do read it but don't understand what you're looking at. The legal profession has spent centuries perfecting the art of hiding the real terms inside the language of the apparent terms.
Here is what the law actually gives you, and what most people discover only after they needed it.
Under Maltese law, specifically Article 992 of the Civil Code, a contract can be annulled on grounds of *dolu* — fraud or deceit — if one party was misled about a material condition of the agreement. That sounds powerful. It isn't, by itself. Because dolu requires you to prove intent, and intent is the hardest thing in law to establish. The easier route, and the one I use before anyone files anything, is the doctrine of *laesio enormis* — the principle that a contract may be challenged where one party received less than half the fair value of what they exchanged. It applies primarily to property transactions under Maltese law, but its logic bleeds into commercial disputes through equity arguments that a competent practitioner can run without ever invoking the doctrine by name.
The more useful weapon in 2026 is the EU's Unfair Contract Terms Directive — Council Directive 93/13/EEC — which was transposed into Maltese law through the Consumer Affairs Act. The Directive renders void any term in a consumer contract that creates a significant imbalance between the parties' rights and obligations, to the detriment of the consumer. Significant imbalance. Two words that carry the weight of an entire negotiation. If a term was not individually negotiated — and in standard-form contracts, almost nothing is — it is automatically subject to the unfairness test. The burden of proof that a term was individually negotiated falls on the seller or supplier. Not on you. On them.
This is what the Kalshi-AppliedXL model doesn't advertise. Every participant in a prediction market on FDA decisions is entering a contract. The terms governing payouts, eligibility, dispute resolution, and market invalidation were drafted by the platform. None of them were negotiated. In the EU — and in Malta, which transposed 93/13/EEC — that makes every non-negotiated term subject to challenge on unfairness grounds. The platforms know this. Which is why their terms of service include jurisdiction clauses pointing to Delaware or the Cayman Islands or somewhere else where 93/13/EEC means nothing.
That jurisdiction clause is the move. It is always the move. The party with the lawyers writes the contract in their forum, under their law, with their judges. The party without the lawyers signs it in three seconds on a mobile screen. I have spent a significant portion of my career attacking jurisdiction clauses — not in court, but before. A well-timed letter to a commercial counterparty pointing out that their jurisdiction clause may be unenforceable against an EU consumer under Article 17 of the Brussels I Recast Regulation (Regulation EU 1215/2012) has a remarkable success rate. The other side recalculates. Settlements happen. No trial required.
There was a period in my life before any of this — before the suits, before I understood that the law was a tool and not a temple — when I signed things I shouldn't have because I thought the document was the relationship, not the terms. I was wrong. The document